E-Cadherin functions as a suppressor of invasion and is downregulated in various cancers including HNSCC in general [36, 37] and in the patients in this study evaluated prior to or immediately after receiving PDT. The gene discussed is CDH1; the disease is head and neck squamous cell carcinoma.